These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 9772936
1. [Efficacy and safety of indapamide 1.5 mg sustained release coated tablets in the therapy of arterial hypertension]. Asmar R. Ann Cardiol Angeiol (Paris); 1998 Feb; 47(2):94-104. PubMed ID: 9772936 [Abstract] [Full Text] [Related]
2. [Renaissance of diuretics in the treatment of hypertension]. Hörl WH. Wien Klin Wochenschr; 1999 Nov 12; 111(21):903-7. PubMed ID: 10599155 [Abstract] [Full Text] [Related]
3. [Treatment of hypertension with indapamide 1.5 mg sustained-release form: synthesis of results]. Guez D, Mallion JM, Degaute JP, Malini PL, Baldwin R, Rodriguez-Pujol D, de Cordoüe A, Barrandon S, Chastang C, Safar M. Arch Mal Coeur Vaiss; 1996 Sep 12; 89 Spec No 4():17-25. PubMed ID: 8952810 [Abstract] [Full Text] [Related]
4. [Therapeutic benefit of a low dose of indapamide: results of a double-blind against placebo European controlled study]. Asmar R, Guez D, Malbezin M, Brault Y, de Cordoue A, Barrandon S, Bruxelles MC, Chastang C. Arch Mal Coeur Vaiss; 1995 Aug 12; 88(8):1083-7. PubMed ID: 8572850 [Abstract] [Full Text] [Related]
11. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection. Gosse P. Expert Rev Cardiovasc Ther; 2006 May 12; 4(3):319-33. PubMed ID: 16716093 [Abstract] [Full Text] [Related]
15. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F. Clin Ther; 2004 Sep 12; 26(9):1436-45. PubMed ID: 15531006 [Abstract] [Full Text] [Related]
16. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study. Mallion JM, Chamontin B, Asmar R, De Leeuw PW, O'Brien E, Duprez D, O'Rourke MF, Rahn KH, Romero R, Battegay E, Hitzenberger G, Safar ME, REASON Project. Am J Hypertens; 2004 Mar 12; 17(3):245-51. PubMed ID: 15001199 [Abstract] [Full Text] [Related]
19. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study. Rosei EA, Rizzoni D, DIMS II (Delapril-Indapamide Multicenter Study II). J Hum Hypertens; 2003 Feb 12; 17(2):139-46. PubMed ID: 12574793 [Abstract] [Full Text] [Related]